Avoiding the regulatory capture of the food and drug administration [9]

Archives of Internal Medicine

Volumn 167, Issue 7, 2007, Pages 732-733

  Egilman, David S ^a   Presler, Amos H ^b   Valentin, Claire S ^b  

^a Never Again Consulting   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; CONFIDENTIALITY; DRUG INDUSTRY; DRUG MONITORING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FUNDING; HUMAN; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL;

EID: 34247121366     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.7.732-b     Document Type: Letter

References (2)

1. Furberg CD, Levin AA, Gross PA, Shapiro RS, Strom BL. The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med. 2006;166:1938-1942.
2. Viscusi WK, Vernon JM, Harrington JE. Economics of Regulation and Antitrust. 3rd ed. Cambridge, Mass: MIT Press; 2000.